文献速递青光眼神经眼科

性别激素在女性和男性青光眼中的作用对比见解

Comparative insights into the role of sex hormones in glaucoma among women and men.
PubMed 文献 · Prog Retin Eye Res · 2025-01-31

本文综述了雌激素、睾酮和孕酮对眼部生理及青光眼的影响,涉及眼压、眼血流和房水流出等参数。证据显示雌激素对青光眼具有保护作用,而雄激素剥夺治疗与青光眼风险降低相关,超生理水平睾酮治疗则显著升高眼压。现有研究结果尚不一致,需标准化研究进一步阐明性激素在青光眼风险和进展中的作用。

要点

  • 较高雌激素水平与较低青光眼风险和较低眼压相关,外源性激素影响尚不一致。
  • 雄激素剥夺治疗者青光眼风险降低,超生理水平睾酮治疗显著升高眼压。
  • 性激素通过影响眼血流和房水流出等参与青光眼病理生理。

核心结论

  • 雌激素在青光眼中可能具有保护作用,但外源性激素对青光眼风险的影响研究结果不一致。
  • 睾酮与眼压的正相关报道较少,雄激素剥夺治疗与青光眼风险降低相关,超生理水平睾酮治疗显著升高眼压。
  • 需要标准化研究进一步阐明雌激素和睾酮在青光眼风险和进展中的作用。

研究设计与样本

  • 本文为综述,检索并汇总了关于主要性激素对眼功能、青光眼发病率及相关参数(如眼压)影响的现有文献。
  • 综述涵盖生理水平及与激素治疗相关的女性和男性数据。

主要发现

  • 雌激素、睾酮和孕酮在视网膜色素上皮和睫状上皮等眼组织中有活性,可能通过影响眼血流和房水流出影响青光眼病理生理。
  • 女性一生中随月经周期、妊娠和绝经波动,总体关联为雌激素较高时青光眼风险较低、眼压较低。
  • 口服避孕药和激素替代疗法等外源性激素似乎也影响青光眼风险,但已发表研究结果不一致。
  • 少数研究报告眼压与血清睾酮呈正相关,雄激素剥夺治疗者青光眼风险降低,超生理水平睾酮的男性化激素治疗显著升高眼压。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 关于外源性激素(口服避孕药和激素替代疗法)对青光眼风险影响的研究结果不一致。
  • 需要标准化研究进一步阐明雌激素和睾酮在青光眼风险和进展中的作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Baseline differences in sex hormone levels between males and females influence tissues including the brain and eye. To investigate the effects of estrogens and androgens on ocular physiology and glaucoma, we review the current literature on the influence of primary sex hormones on ocular function, glaucoma incidence and related parameters like intraocular pressure (IOP) at physiologic levels and related to hormone therapies in men and women. These articles reveal activity of estrogen, testosterone, and progesterone within ocular tissues including the retinal pigment epithelium and ciliary epithelium where they likely influence glaucoma pathophysiology through effects on ocular blood flow and aqueous outflow. A growing body of evidence demonstrates a protective role of estrogen in glaucoma. With fluctuations across a woman's lifetime through menstrual phases, pregnancy, and menopause, the general association seen is a lower risk of glaucoma and lower IOP with higher estrogen. Exogenous hormones in the form of oral contraceptive pills and hormone replacement therapy also appear to affect glaucoma risk, although published findings are inconsistent. Few studies have reported a positive association between IOP and serum testosterone, and men treated with androgen deprivation therapy have shown a reduced risk of glaucoma while masculinizing hormone therapies at supra-physiologic testosterone levels have significantly increased IOP. Sex hormone perturbations affect components of glaucoma pathogenesis including IOP and ocular blood flow and overlap with known risk factors like age and sex. Standardized studies are needed to further elucidate the roles of estrogen and testosterone in glaucoma risk and progression.

来源:Prog Retin Eye Res,查看原文。版权归原作者所有。

引用

  1. Zhao SH, Kim CK, Al-Khaled T, et al. Comparative insights into the role of sex hormones in glaucoma among women and men. Prog Retin Eye Res. 2025. PMID: 39894297. doi:10.1016/j.preteyeres.2025.101336

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。